Verastem Inc (USD)
VSTM
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range1.92 | 2.09
52-Wk Range0.83 | 3.66
Last Close1.97
Mkt Cap (m)146.47
Dividend yield-
ISINUS92337C1045
Volume2,004,289
Exchange VenueNAS

Company Profile

Verastem Inc is a biopharmaceutical company engaged in discovering and developing drugs to improve outcomes for patients with cancer. Its product candidates include duvelisib and defactinib.

Key Information
Price/Earning-
Price/Book6.81
Price/Sales10.25
P/CF-
Rev Growth (3 year avg)-
EPS Growth (3 year avg)-
Operating Margin % -
Net Margin %-
Return on Equity-
Debt/Equity-

Documents

Prospectus
en 12/10/2018
Annual Report
en 31/12/2018

Financials

Income Statement
USD201420152016201720182019
Revenue (m)27-
Operating Income (m)-54-58-37-68-95-
Net Income (m)-53-58-36-68-72-
Basic EPS-2.07-1.61-0.99-1.76-1.12-
Avg. Diluted Shares Outstanding (m)2636373869-
Balance Sheet
USD201420152016201720182019
Current Assets (m)951118188253-
Non Current Assets (m)322224-
Total Assets (m)991138490277-
Current Liabilities (m)910111737-
Total Liabilities (m)------
Total Equity (m)891027258124-
Cash Flows
USD201420152016201720182019
Operating Cash Flows (m)-37-46-29-57-75-
Capital Expenditure (m)-2--24-
Figures are quoted in USD unless stated otherwise
-
No change
$
1.97
Last Price